Pharmaceutical Manufacturing Glossary

Aseptic Processing
Manufacturing a sterile product by sterilising components and solution separately and assembling them under conditions that prevent contamination, used when the product cannot survive terminal sterilisation.
Batch Manufacturing Record (BMR)
The authorised document for a batch, completed as the batch is made, recording every material, parameter, check and signature — the primary evidence that a batch was made as approved.
Cleaning Validation (MACO)
Demonstrating that cleaning between products leaves no more than the maximum allowable carryover, calculated from toxicological or dose-based limits and verified analytically.
Containment (OEB/OEL)
Engineering and procedural controls that keep operator exposure to a potent compound below its occupational exposure limit, banded into occupational exposure bands from OEB 1 to OEB 5.
Engineering Batch
A full-scale trial batch run to confirm the process on the receiving site's equipment before validation batches, usually not intended for commercial sale.
Grade A / Grade B
Cleanroom classifications for sterile manufacturing — Grade A is the critical filling zone, Grade B its immediate background — defined by particle counts at rest and in operation plus microbiological limits.
ICH Q1A(R2)
The ICH guideline that defines stability testing requirements for new drug substances and products — storage conditions, testing frequency and data needed to support a shelf life.
Loan Licence Manufacturing
Manufacturing at another company's licensed premises under a licence issued in the marketing company's name, with defined oversight of the batch by the licence holder's QA.
Media Fill
A process simulation in which sterile growth medium replaces product, filled and incubated to show that the aseptic process can produce sterile units.
Out of Trend (OOT)
A stability result that is still within specification but has moved away from the established trend — an early warning that a specification failure may be coming.
Photostability (ICH Q1B)
Testing a product's response to light exposure, using defined visible and near-UV doses, to decide whether light-protective packaging or labelling is required.
Process Validation
Documented evidence that a manufacturing process, operated within defined parameters, consistently produces product meeting its specification.
Quality Agreement
The written agreement defining who is responsible for which GMP activity between the contract giver and the contract acceptor — release, change control, deviations, audits and recalls.
Shelf Life
The period during which a product remains within specification when stored under the conditions on its label, supported by stability data rather than extrapolation alone.
Technology Transfer
The documented handover of a product and its process from one site to another, so the receiving site can make it to the same specification with evidence rather than hope.
Terminal Sterilisation
Sterilising the product in its final sealed container, usually by moist heat, giving a calculable and verifiable sterility assurance level.